Skip to main content
. 2022 Jan 13;13:20406223211067631. doi: 10.1177/20406223211067631

Figure 3.

Figure 3.

EOS METAVIR scores in SVR cases (n = 59) among the entire cohort (n = 85) with varying baseline METAVIR scores. (a) The distribution of EOS fibrosis stages. (b) The rates of fibrosis clearance and significant fibrosis (METAVIR score F2/F3/F4) at EOS. (c) The distribution of EOS activity grades. (d) The rate of activity absence (METAVIR score A0) at EOS. For (b, d), asterisks () denote a p-value <0.05 (statistically significant; Fisher’s exact test).

EOS, end of surveillance; SVR, sustained virological response.